Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery

Journal of Drug Targeting

Volumn 15, Issue 4, 2007, Pages 295-301

  Bondi', Maria Luisa ^a   Azzolina, Antonina ^b   Craparo, Emanuela Fabiola ^c   Lampiasi, Nadia ^b   Capuano, Giulia ^c   Giammona, Gaetano ^c   Cervello, Melchiorre ^b  

^a CNR   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cationic solid lipid nanoparticles; Cell transfection; Cytotoxicity; Gene therapy; Liver cancer; Non viral DNA vectors

Indexed keywords

CATION; DEOXYRIBONUCLEASE I; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; GLYCEROL BEHENATE; PLASMID DNA; POLOXAMER; SOLID LIPID NANOPARTICLE; ACYLGLYCEROL; BETA GALACTOSIDASE; DNA; DRUG CARRIER; NANOPARTICLE;

ARTICLE; CANCER CELL; CYTOTOXICITY; DISTILLATION; DNA VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; MICROEMULSION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; GENE TRANSFER; GENETICS; TUMOR CELL LINE;

BETA-GALACTOSIDASE; CATIONS; CELL LINE, TUMOR; CELL SURVIVAL; DNA; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; GLYCERIDES; HUMANS; NANOPARTICLES; PARTICLE SIZE; TRANSFECTION;

EID: 34447517618     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701324698     Document Type: Article

References (22)

1. Anderson, WF (1998) Human gene therapy. Nature, 392, pp. 25-30.
2. Benns, JM and Kim, SW (2000) Tailoring new gene delivery designs for specific targets. J Drug Target, 8, pp. 1-12.
3. Conry, RM, White, SA, Fultz, PN, Khazaeli, MB, Strong, TV, Allen, KO, Barlow, DL, Moore, SE, Coan, PN, Davis, I., Curiel, DT and Buglio, AF Lo (1998) Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen. Clin Cancer Res, 4, pp. 2903-2912.
4. Davis, SS (1997) Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotechnol, 15, pp. 217-224.
5. El-Aneed, A. (2004) An overview of current delivery systems in cancer gene therapy. J Control Rel, 94, pp. 1-14.
6. Hanke, P., Serwe, M., Dombrowski, F., Sauerbruch, T. and Caselmann, WH (2002) DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice. Cancer Gene Ther, 9, pp. 346-355.
7. Itaka, K., Yamauchi, K., Harada, A., Nakamura, K., Kawaguchi, H. and Kataoka, K. (2003) Polyion complex micelles from plasmid DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer as serum-tolerable polyplex system: Physicochemical properties of micelles relevant to gene transfection efficiency. Biomaterials, 24, pp. 4495-4506.
8. Kawabata, K., Takakura, Y. and Hashida, M. (1995) The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharm Res, 12, pp. 825-830.
9. Licciardi, M., Campisi, M., Cavallaro, G., Cervello, M., Azzolina, A. and Giammona, G. (2006) Synthesis and characterization of polyaminoacidic polycations for gene delivery. Biomaterials, 27, pp. 2066-2075.
10. Mehnert, W. and Mader, K. (2001) Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 47, pp. 165-196.
11. Nabel, GJ (1999) Development of optimized vectors for gene therapy. Proc Natl Acad Sci USA, 96, pp. 324-326.
12. Olbrich, C., Bakowsky, U., Lehr, CM, Muller, RH and Kneuer, C. (2001) Cationic solid lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Rel, 77, pp. 345-355.
13. Pedersen, N., Hansen, S., Heydenreich, AV, Kristensen, HG and Poulsen, HS (2006) Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm, 62, pp. 155-162.
14. Peng, KW and Vile, R. (1999) Vector development for cancer gene therapy. Tumor Target, 4, pp. 3-11.
15. Schwarz, C. and Mehnert, W. (1995) Sterilization of drug-free and tetracaine-loaded solid lipid nanoparticles (SLN).pp. 485-486.
16. Schwarz, C. and Mehnert, W. (1997) Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm, 157, pp. 171-179.
17. Shi, F., Rakhmilevich, AL, Heise, CP, Oshikawa, K., Sondel, PM, Yang, NS and Mahvi, MD (2002) Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. Mol Cancer Ther, 1, pp. 949-957.
18. Tabatt, K., Sameti, M., Olbrich, C., Muller, RH and Lehr, CM (2004) Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticles-mediated gene transfer. Eur J Pharm Biopharm, 57, pp. 155-162.
19. Walther, W., Stein, U., Fichtner, I., Voss, C., Schmidt, T., Schleef, M., Nellessen, T. and Schlag, PM (2002) Intratumoral low-volume jet-injection for efficient nonviral gene transfer. Mol Biotechnol, 21, pp. 105-115.
20. Weijun, L., François Jr, N. and Francis, SC (2004) GALA: A designed synthetic pHresponsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Del Rev, 56, pp. 967-985.
21. Wissing, SA, Kayser, O. and Muller, RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Del Rev, 56, pp. 1257-1272.
22. Yang, SC, Lu, LF, Cai, Y., Zhu, JB, Liang, BW and Yang, CZ (1999) Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Rel, 59, pp. 299-307.